Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (191-200 of 359) with videos related to

Pageof 36
Sort By:
Experimental Gerontology|August 31, 2010
Serum N-glycan profile shift during human ageingValerie Vanhooren, Sylviane Dewaele, Claude Libert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 19, 2015
A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42Kristel Sleegers, Karolien Bettens, Arne De Roeck, et al.
Alzheimer'S Research & Therapy|September 12, 2020
Amyloid-β<sub>1-43</sub> cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutationsFederica Perrone, Maria Bjerke, Elisabeth Hens, et al.
Molecular Psychiatry|July 11, 2023
Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protectionRita Cacace, Lujia Zhou, Elisabeth Hendrickx Van de Craen, et al.
Neurobiology of Aging|November 29, 2011
DLB and PDD: a role for mutations in dementia and Parkinson disease genes?Bram Meeus, Aline Verstraeten, David Crosiers, et al.
The Lancet. Neurology|July 5, 2015
Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing studyElise Cuyvers, Arne De Roeck, Tobi Van den Bossche, et al.
Neurology|June 18, 2026
Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data SetAravind Ganesh, Eric E Smith, Jop Mostert, et al.
Alzheimer'S Research & Therapy|March 17, 2018
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translationCharlotte E Teunissen, Markus Otto, Sebastiaan Engelborghs, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2013
The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation studyJose L Molinuevo, Juan Domingo Gispert, Bruno Dubois, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 21, 2015
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's diseaseAnn De Vos, Dirk Jacobs, Hanne Struyfs, et al.
Pageof 36

Showing results (191-200 of 359) with videos related to

Sort By:
Pageof 36
Experimental Gerontology|August 31, 2010
Serum N-glycan profile shift during human ageingValerie Vanhooren, Sylviane Dewaele, Claude Libert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 19, 2015
A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42Kristel Sleegers, Karolien Bettens, Arne De Roeck, et al.
Alzheimer'S Research & Therapy|September 12, 2020
Amyloid-β<sub>1-43</sub> cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutationsFederica Perrone, Maria Bjerke, Elisabeth Hens, et al.
Molecular Psychiatry|July 11, 2023
Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protectionRita Cacace, Lujia Zhou, Elisabeth Hendrickx Van de Craen, et al.
Neurobiology of Aging|November 29, 2011
DLB and PDD: a role for mutations in dementia and Parkinson disease genes?Bram Meeus, Aline Verstraeten, David Crosiers, et al.
The Lancet. Neurology|July 5, 2015
Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing studyElise Cuyvers, Arne De Roeck, Tobi Van den Bossche, et al.
Neurology|June 18, 2026
Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data SetAravind Ganesh, Eric E Smith, Jop Mostert, et al.
Alzheimer'S Research & Therapy|March 17, 2018
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translationCharlotte E Teunissen, Markus Otto, Sebastiaan Engelborghs, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2013
The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation studyJose L Molinuevo, Juan Domingo Gispert, Bruno Dubois, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 21, 2015
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's diseaseAnn De Vos, Dirk Jacobs, Hanne Struyfs, et al.
Pageof 36